the-us.-must-not-cave-to-israel’s-demands-for-help

Israel’s war of choice with Iran is proving to be far less decisive than President Traitor 47 initially believed when he praised Israel’s performance as “excellent.” What now appears to be an escalating, inconclusive conflict with no clear end in sight will soon force The Traitor into a challenging decision: end theContinue Reading

the-‘no-kings’-protests-were-historic.-we-can’t-stop-there

The huge decentralized turnout for No Kings Day has shown that grassroots power can be a major force against the momentum of the The Traitor regime. The protests were auspicious, with 5 million people participating in 2,100 gatherings nationwide. Activists are doing what the national Democratic Party leadership has failed to doContinue Reading

who-will-have-the-upper-hand:-israel-or-iran?

Israel’s air force dominates the skies while Iran relies heavily on ballistic missiles and drones. , It’s been several days now since Israel launched its surprise attack on Iran. The conflict has since escalated with each side launching dozens of strikes. And because the warring sides don’t share a border, theContinue Reading

By Beth Ridgeway  NASA’s Student Launch competition celebrated its 25th anniversary on May 4, just north of NASA’s Marshall Space Flight Center in Huntsville, Alabama, bringing together more than 980 middle school, high school, college, and university students from across the U.S. to showcase and launch their high-powered rocketry designs. The event marked the conclusionContinue Reading

most-anticipated-lgbtq+-adult-fiction:-july-december-2025

Once again, Romance will have its own post later this week! Today’s post is sponsored by Janelle Cressida and her brand-new m/m fantasy romance, Son of the Moon, on sale now for $2.99! Some acts of kindness change more than just one life… Buy it: Amazon *** Hot Girls With BallsContinue Reading

Immune Modulation in MDS: Our Core Strategies Need to Change

MILAN — Immune-based treatments continue to fall short in myelodysplastic syndromes (MDS). Now, experts from the European Hematology Association’s (EHA) Specialized Working Group on MDS here at the EHA 2src25 Congress are reevaluating their core strategies, from clinical trial endpoints to patient selection and timing. The researchers are suggesting the need for a shift inContinue Reading